Search by Drug Name or NDC

    NDC 75834-0135-05 RIVASTIGMINE TARTRATE 4.5 mg/1 Details

    RIVASTIGMINE TARTRATE 4.5 mg/1

    RIVASTIGMINE TARTRATE is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Nivagen Pharmaceuticals, Inc.. The primary component is RIVASTIGMINE TARTRATE.

    Product Information

    NDC 75834-0135
    Product ID 75834-135_e272f7d1-d782-4ff1-919c-784c91ee024d
    Associated GPIs 62051040200130
    GCN Sequence Number 040157
    GCN Sequence Number Description rivastigmine tartrate CAPSULE 4.5 MG ORAL
    HIC3 J1B
    HIC3 Description CHOLINESTERASE INHIBITORS
    GCN 90398
    HICL Sequence Number 018527
    HICL Sequence Number Description RIVASTIGMINE TARTRATE
    Brand/Generic Generic
    Proprietary Name RIVASTIGMINE TARTRATE
    Proprietary Name Suffix n/a
    Non-Proprietary Name RIVASTIGMINE TARTRATE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 4.5
    Active Ingredient Units mg/1
    Substance Name RIVASTIGMINE TARTRATE
    Labeler Name Nivagen Pharmaceuticals, Inc.
    Pharmaceutical Class Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203844
    Listing Certified Through 2024-12-31

    Package

    NDC 75834-0135-05 (75834013505)

    NDC Package Code 75834-135-05
    Billing NDC 75834013505
    Package 500 CAPSULE in 1 BOTTLE, PLASTIC (75834-135-05)
    Marketing Start Date 2017-09-04
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 83bd2ff6-1d8b-4cac-a37b-fd01dc3f34a1 Details

    Revised: 2/2022